Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
European Society of Hypertension.
The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension.
J HYPERTENS. 2021; 39(1): 190-195.
Doi: 10.1097/HJH.0000000000002703
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Zweiker Robert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The Covid-19 pandemic caused a shutdown of healthcare systems in many countries. We explored the impact on hypertension care in the Excellence Center (EC) network of the European Society of Hypertension. We conducted a 17-question electronic survey among ECs. Overall, 52 ECs from 20 European and three non-European countries participated, providing hypertension service for a median of 1500 hypertensive patients per center per year. Eighty-five percent of the ECs reported a shutdown lasting for 9 weeks (range 0-16). The number of patients treated per week decreased by 90%: from a median of 50 (range 10-400) before the pandemic to a median of 5.0 (range 0-150) during the pandemic (P < 0.0001). 60% of patients (range 0-100%) declared limited access to medical consultations. The majority of ECs (57%) could not provide 24-h ambulatory BP monitoring, whereas a median of 63% (range 0-100%) of the patients were regularly performing home BP monitoring. In the majority (75%) of the ECs, hypertension service returned to normal after the first wave of the pandemic. In 66% of the ECs, the physicians received many questions regarding the use of renin-angiotensin system (RAS) blockers. Stopping RAS-blocker therapy (in a few patients) either by patients or physicians was reported in 27 and 36.5% of the ECs. Patient care in hypertension ECs was compromised during the Covid-19-related shutdown. These data highlight the necessity to develop new strategies for hypertension care including virtual clinics to maintain services during challenging times.
- Find related publications in this database (using NLM MeSH Indexing)
- Angiotensin Receptor Antagonists - therapeutic use
- Angiotensin-Converting Enzyme Inhibitors - therapeutic use
- Antihypertensive Agents - therapeutic use
- Blood Pressure Monitoring, Ambulatory -
- COVID-19 - epidemiology
- Delivery of Health Care -
- Delivery of Health Care - epidemiology
- Health Facilities -
- Health Services Accessibility -
- Humans -
- Hypertension - drug therapy
- Pandemics -
- Renin-Angiotensin System -
- SARS-CoV-2 -
- Surveys and Questionnaires -
- Find related publications in this database (Keywords)
- Covid-19
- blood pressure
- hypertension routine care
- renin-angiotensin system inhibitors